Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filedlitigationCriticalhttps://patents.darts-ip.com/?family=42042466&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ECSP961736(A)"Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filedfiledCritical
Priority to ECSP961736priorityCriticalpatent/ECSP961736A/en
Publication of ECSP961736ApublicationCriticalpatent/ECSP961736A/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Medicinal Preparation
(AREA)
Abstract
Se proporcionan formulaciones pediátricas en forma de suspensión líquida acuosa que contienen amoxicilina trihidrato y clavulanato potásico en una proporción desde 6:1 hasta 8:1 para su utilización en un régimen de dosificación BID para el tratamiento de infecciones bacterianas.Pediatric formulations in the form of an aqueous liquid suspension containing amoxicillin trihydrate and potassium clavulanate in a ratio of 6: 1 to 8: 1 are provided for use in a BID dosing regimen for the treatment of bacterial infections.
PHARMACEUTICAL COMPOSITION LIQUID ORAL ADMINISTRATION THAT INCLUDES WATER, METHYL ACID-2- (2'-CHLORINE-6'-FLUOROANILINO) PHENYLACETIC, AND A SUSPENSION AGENT, WITH A PH BETWEEN 4.5 AND 5.5; PREPARATION METHOD; USE TO TREAT A DEPENDENT DISORDER